{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:57:28Z","timestamp":1771473448690,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.mehy.2007.06.019","type":"journal-article","created":{"date-parts":[[2007,8,8]],"date-time":"2007-08-08T11:22:54Z","timestamp":1186572174000},"page":"572-577","source":"Crossref","is-referenced-by-count":10,"title":["Chemo brain \u2013 A psychotropic drug phenomenon?"],"prefix":"10.1016","volume":"70","author":[{"given":"Grace E.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2007.06.019_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2710.2006.00726.x","article-title":"Is \u2018chemo-fog\u2019\/\u2018chemo-brain\u2019 caused by cancer chemotherapy?","volume":"31","author":"Raffa","year":"2006","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"10.1016\/j.mehy.2007.06.019_bib2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1188\/05.CJON.713-721","article-title":"The phenomenon of chemo brain","volume":"9","author":"Staat","year":"2005","journal-title":"Clin J Oncol Nurs"},{"issue":"11","key":"10.1016\/j.mehy.2007.06.019_bib3","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1200\/JCO.2004.08.094","article-title":"Cognitive impairment associated with chemotherapy for cancer: report of a workshop","volume":"22","author":"Tannock","year":"2004","journal-title":"J Clin Oncol"},{"issue":"31","key":"10.1016\/j.mehy.2007.06.019_bib4","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1200\/JCO.2005.01.6550","article-title":"Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study","volume":"3","author":"Fan","year":"2005","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.mehy.2007.06.019_bib5","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1002\/cncr.20272","article-title":"The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial","volume":"100","author":"Wefel","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.mehy.2007.06.019_bib6","first-page":"217","article-title":"White matter disease induced by high-dose chemotherapy: longitudinal study with mr imaging and proton spectroscopy","volume":"19","author":"Brown","year":"1998","journal-title":"AJNR"},{"issue":"4","key":"10.1016\/j.mehy.2007.06.019_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1084-3612(03)00055-8","article-title":"Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives","volume":"8","author":"Saykin","year":"2003","journal-title":"Semin Clin Neuropsychiat"},{"issue":"2","key":"10.1016\/j.mehy.2007.06.019_bib8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.20.2.485","article-title":"Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma","volume":"20","author":"Ahles","year":"2002","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.mehy.2007.06.019_bib9","doi-asserted-by":"crossref","first-page":"22.1","DOI":"10.1186\/jbiol50","article-title":"CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo","volume":"5","author":"Dietrich","year":"2006","journal-title":"J Biol"},{"issue":"7","key":"10.1016\/j.mehy.2007.06.019_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/jbiol50","article-title":"CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo","volume":"5","author":"Dietrich","year":"2006","journal-title":"J Biol"},{"issue":"1","key":"10.1016\/j.mehy.2007.06.019_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1385\/JMN:27:1:029","article-title":"Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines","volume":"27","author":"Levokovitz","year":"2005","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.mehy.2007.06.019_bib12","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0006-2952(99)00156-2","article-title":"Effects of psychotropic drugs on cell proliferation and differentiation","volume":"58","author":"Nordenberg","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2007.06.019_bib13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0920-9964(01)00308-5","article-title":"The association between schizophrenia and cancer: a population based mortality study [abstract]","volume":"57","author":"Cohen","year":"2002","journal-title":"Schizophr Res"},{"key":"10.1016\/j.mehy.2007.06.019_bib14","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.bjc.6603259","article-title":"Cancer risk among users of neuroleptic medication: a population-based cohort study","volume":"95","author":"Dalton","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.mehy.2007.06.019_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0920-9964(94)90028-0","article-title":"The occurrence of cancer in first admitted schizophrenic patients [abstract]","volume":"12","author":"Mortensen","year":"1994","journal-title":"Schizophr Res"},{"key":"10.1016\/j.mehy.2007.06.019_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/JMN:22:3:189","article-title":"Characterization of phenothiazine-induced apoptosis in neuroblastoma and glioma cell lines","volume":"22","author":"Gil-Ad","year":"2004","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.mehy.2007.06.019_bib17","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/sj.bjp.0703224","article-title":"Inhibition by various antipsychotic drugs of the G-protein-activated inwardly rectifying K+ (GIRK) channels expressed in Xenopus oocytes","volume":"129","author":"Kobayashi","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.mehy.2007.06.019_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0165-1781(87)90090-4","article-title":"Blood to brain distribution of neuroleptics [abstract]","volume":"20","author":"Sunderland","year":"1987","journal-title":"Psychiat Res"},{"issue":"6","key":"10.1016\/j.mehy.2007.06.019_bib19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1023\/A:1015152021192","article-title":"Evaluation of the neurotoxic activity of typical and atypical neuroleptics: relevance to iatrogenic extrapyramidal symptoms","volume":"21","author":"Gil-Ad","year":"2001","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"10.1016\/j.mehy.2007.06.019_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-2005-864121","article-title":"Paroxetine serum concentrations in depressed patients and response to treatment [abstract]","volume":"38","author":"Gilles","year":"2005","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1016\/j.mehy.2007.06.019_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007691-200006000-00007","article-title":"Simultaneous determination of human plasma levels of four selective serotonin reuptake inhibitors by high-performance liquid chromatography [abstract]","volume":"22","author":"Lucca","year":"2000","journal-title":"Ther Drug Monit"},{"issue":"4","key":"10.1016\/j.mehy.2007.06.019_bib22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0893-133X(00)00116-0","article-title":"Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy","volume":"23","author":"Bolo","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2007.06.019_bib23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1176\/jnp.5.3.322","article-title":"Human brain fluoxetine concentrations","volume":"5","author":"Karson","year":"1993","journal-title":"J Neuropsychiat Clin Neurosci"},{"issue":"15","key":"10.1016\/j.mehy.2007.06.019_bib24","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2006.08.6165","article-title":"Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study","volume":"25","author":"Munster","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.mehy.2007.06.019_bib25","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1017\/S0317167100026640","article-title":"Pseudoatrophy of the brain with valproic acid monotherapy","volume":"14","author":"McLachlan","year":"1987","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.mehy.2007.06.019_bib26","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ana.410380423","article-title":"Reversible dementia and apparent brain atrophy during valproate therapy","volume":"38","author":"Papazian","year":"1995","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.mehy.2007.06.019_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1157.1998.tb01270.x","article-title":"Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment","volume":"39","author":"Guerrini","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.mehy.2007.06.019_bib28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00701-003-0073-7","article-title":"The potential for strategies using micronutrients and heterocyclic drugs to treat invasive gliomas","volume":"145","author":"Rooprai","year":"2003","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.mehy.2007.06.019_bib29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.mp.4000712","article-title":"Adult brain neurogenesis and psychiatry: a novel theory of depression","volume":"5","author":"Jacobs","year":"2000","journal-title":"Mol Psychiat"},{"key":"10.1016\/j.mehy.2007.06.019_bib30","doi-asserted-by":"crossref","first-page":"S481","DOI":"10.1016\/j.euroneuro.2004.09.002","article-title":"Alterations of neuroplasticity in depression: the hippocampus and beyond","volume":"14","author":"Fuchs","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.mehy.2007.06.019_bib31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.mehy.2007.06.019_bib32","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1523\/JNEUROSCI.3741-04.2005","article-title":"Brain derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus","volume":"25","author":"Sairanen","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2007.06.019_bib33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-2999(00)00904-3","article-title":"Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro","volume":"411","author":"Manev","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"10.1016\/j.mehy.2007.06.019_bib34","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4088\/JCP.v67n1116","article-title":"Antidepressants and driving ability: results from a clinical study","volume":"67","author":"Brunnauer","year":"2006","journal-title":"J Clin Psychiat"},{"key":"10.1016\/j.mehy.2007.06.019_bib35","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.4088\/JCP.v67n1113","article-title":"A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment","volume":"67","author":"Fava","year":"2006","journal-title":"J Clin Psychiat"},{"issue":"4","key":"10.1016\/j.mehy.2007.06.019_bib36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00265843","article-title":"The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects [abstract]","volume":"40","author":"Allen","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.mehy.2007.06.019_bib37","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0006-3223(91)90179-P","article-title":"Memory effects of clomipramine treatment: relationship to CSF monoamine metabolites and drug concentrations in plasma [abstract]","volume":"30","author":"Bartfai","year":"1991","journal-title":"Biol Psychiat"},{"issue":"3","key":"10.1016\/j.mehy.2007.06.019_bib38","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/026988110201600305","article-title":"Memory performance in panic disorder patients after chronic use of clomipramine [abstract]","volume":"16","author":"De Carvalho","year":"2002","journal-title":"J Psychopharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2007.06.019_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1385\/BTER:83:2:139","article-title":"Effects of lithium on thrombopoesis in patients with low platelet cell counts following chemotherapy or radiotherapy [abstract]","volume":"83","author":"Hager","year":"2001","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.mehy.2007.06.019_bib40","unstructured":"Meredith EJ, Holder MJ, Chamba A, et al. The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential antitumor target for psychotropics. FASEB J. <http:\/\/www.fasebj.org\/cgi\/doi\/10.1096\/fj.04-3477fje> [published on-line May 3, 2005; retrieved May 11, 2007]."},{"key":"10.1016\/j.mehy.2007.06.019_bib41","unstructured":"International Network for Cancer Treatment and Research (INCTR) Report, Institut Pasteur; 2006. <http:\/\/inctr.org\/publications\/report\/2005_04_04.shtml> [retrieved May 11, 2007]."},{"issue":"1","key":"10.1016\/j.mehy.2007.06.019_bib42","first-page":"313","article-title":"Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines","volume":"62","author":"Crawford","year":"2002","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.mehy.2007.06.019_bib43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.tpj.6500373","article-title":"Haloperidol induces apoptosis via the sigma2 receptor system and Bcl-XS (abstract)","volume":"6","author":"Wei","year":"2006","journal-title":"Pharmacogenomics J"},{"issue":"30","key":"10.1016\/j.mehy.2007.06.019_bib44","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.2174\/138161206778559614","article-title":"Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals [abstract]","volume":"12","author":"Hashimoto","year":"2006","journal-title":"Curr Pharm Des"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987707004331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987707004331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T05:41:17Z","timestamp":1737351677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987707004331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0306987707004331"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2007.06.019","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}